Humana Inc (HUM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 5,061,000 | 13,558,000 | 5,153,000 | 4,864,000 | 3,394,000 |
Marketable Securities | 13,881,000 | 13,124,000 | 13,037,000 | 13,092,000 | 13,192,000 |
Receivables | 1,674,000 | 1,609,000 | 3,369,000 | 3,174,000 | 1,814,000 |
Other current assets | 5,567,000 | 5,420,000 | 5,658,000 | 5,710,000 | 6,493,000 |
TOTAL | $26,183,000 | $33,711,000 | $27,217,000 | $26,840,000 | $24,893,000 |
Non-Current Assets | |||||
PPE Net | 3,221,000 | 3,218,000 | 3,121,000 | 3,189,000 | 3,073,000 |
Investments And Advances | 1,129,000 | 1,113,000 | 554,000 | 530,000 | 921,000 |
Intangibles | 9,142,000 | 9,096,000 | 8,911,000 | 11,139,000 | 11,092,000 |
Other Non-Current Assets | 3,380,000 | 3,627,000 | 7,017,000 | 4,610,000 | 4,379,000 |
TOTAL | $16,872,000 | $17,054,000 | $19,603,000 | $19,468,000 | $19,465,000 |
Total Assets | $43,055,000 | $50,765,000 | $46,820,000 | $46,308,000 | $44,358,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 2,092,000 | 2,799,000 | 1,541,000 | 1,690,000 | 1,953,000 |
Accounts payable and accrued liabilities | 14,502,000 | 16,003,000 | 15,437,000 | 15,237,000 | 12,798,000 |
Other current liabilities | N/A | N/A | 206,000 | N/A | N/A |
TOTAL | $17,178,000 | $25,051,000 | $17,839,000 | $17,532,000 | $15,331,000 |
Non-Current Liabilities | |||||
Long Term Debt | 9,034,000 | 7,798,000 | 11,290,000 | 11,285,000 | 10,541,000 |
Deferred Revenues | 286,000 | 6,012,000 | 264,000 | 288,000 | 254,000 |
Other Non-Current Liabilities | 1,476,000 | 1,601,000 | 2,180,000 | 2,149,000 | 2,383,000 |
TOTAL | $10,507,000 | $9,397,000 | $13,471,000 | $13,434,000 | $12,924,000 |
Total Liabilities | $27,685,000 | $34,448,000 | $31,310,000 | $30,966,000 | $28,255,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 124,975 | 126,600 | 126,554 | 126,493 | 126,634 |
Common Shares | 33,000 | 33,000 | 33,000 | 33,000 | 33,000 |
Retained earnings | 25,492,000 | 25,606,000 | 24,511,000 | 23,915,000 | 23,086,000 |
Other shareholders' equity | -1,245,000 | -1,404,000 | -1,031,000 | -549,000 | 65,000 |
TOTAL | $15,370,000 | $16,317,000 | $15,510,000 | $15,342,000 | $16,103,000 |
Total Liabilities And Equity | $43,055,000 | $50,765,000 | $46,820,000 | $46,308,000 | $44,358,000 |